A Phase 2 interventional study of Laparoscopic surgical navigation system and Indocyanine Green in Liver Resection, sponsored by Zhujiang Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-01-22.
Sponsored by Zhujiang Hospital · Phase 2, Interventional, and Treatment
The aim of this study was to evaluate the feasibility and efficacy of a novel real-time navigation way for laparoscope liver resection, which was fused images comprising 3D imaging and indocyanine green Fluorescence imaging (fusion IGFI).
During liver resection, surgeons cannot completely view the intraparenchymal structure. Although a fluorescent imaging technique using indocyanine green has recently been developed for hepatobiliary surgery, limitations in its application for real-time navigation persist. A nove augmented reality surgery navigation system (ARSNS) can be combined with indocyanine green Fluorescence imaging to guide the surgery real-time.
Zhujiang Hospital is the lead sponsor of 199 studies on the registry; 96 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Hepatectomy procedures were performed under Laparoscopic surgical navigation system and Indocyanine Green guidance.
Device: Laparoscopic surgical navigation system · Drug: Indocyanine Green
We will use this navigation system to guide de liver resection.
ICG was administered 24 hours before the operation or intravenously after clamping the Glissonian sheaths flowing in the cancer-bearing hepatic segment, or directly into the portal branches supplying blood flow to the tumor-bearing hepatic segment, after puncturing of the target segments under intraoperative ultrasonography guidance.
Liver resection navigation success rate
Whether this technique successfully displayed the pre-resection line during the surgery were recorded.
Time frame: intraoperative
Postoperative complication rate
The Postoperative complications were recorded.
Time frame: 3 months
Operative outcomes
Operative outcomes such as operative time, estimated blood loss and blood transfusion were recorded.
Time frame: intraoperative
This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zhujiang Hospital